Aton Ra Partners Madrigal Pharmaceuticals, Inc. Transaction History
Aton Ra Partners
- $50.1 Million
- Q4 2023
A detailed history of Aton Ra Partners transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Aton Ra Partners holds 3,433 shares of MDGL stock, worth $1.15 Million. This represents 1.58% of its overall portfolio holdings.
Number of Shares
3,433
Previous 3,857
10.99%
Holding current value
$1.15 Million
Previous $563,000
41.03%
% of portfolio
1.58%
Previous 1.18%
Shares
7 transactions
Others Institutions Holding MDGL
# of Institutions
296Shares Held
21.9MCall Options Held
819KPut Options Held
644K-
Janus Henderson Group PLC London, X02.48MShares$830 Million0.28% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$684 Million29.57% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$679 Million6.48% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$667 Million6.74% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$661 Million4.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.73B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...